Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Stopping Without Validation Data in Weakly Supervised Learning.

IEEE transactions on pattern analysis and machine intelligence·2026
Same author

Corrigendum to "Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide" [Biomaterials 42 (2015) 16442].

Biomaterials·2026
Same author

Functional Characterisation of NF-YCs in True Leaf Biomass Accumulation.

Plants (Basel, Switzerland)·2026
Same author

Sex- and age-dependent physiological adaptation of captive père david's deer revealed by multi-omics analysis.

BMC genomics·2026
Same author

Correction to "Triphase Interface Synthesis of Plasmonic Gold Bellflowers as Near-Infrared Light Mediated Acoustic and Thermal Theranostics".

Journal of the American Chemical Society·2026
Same author

Instance-dependent Early Stopping for Adaptive Data Pruning.

IEEE transactions on pattern analysis and machine intelligence·2026

Related Experiment Video

Updated: May 24, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

[Quantitative evaluations of ischemic stroke based on meta-analysis].

Xue-wen Yu1, Zhe Zhang, Jian Yang

  • 1Department of Radiology, Xi'an Jiaotong University, Xi'an, China.

Zhonghua Yi Xue Za Zhi
|February 16, 2012
PubMed
Summary

This meta-analysis shows apparent diffusion coefficient (ADC) values change across ischemic stroke stages. Lower ADC values in early stages indicate stroke progression and can guide treatment decisions.

Related Experiment Videos

Last Updated: May 24, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Context:

  • Ischemic stroke diagnosis and staging are critical for effective treatment.
  • Diffusion-weighted imaging-magnetic resonance imaging (DWI-MRI) provides quantitative metrics like apparent diffusion coefficient (ADC).
  • Understanding ADC evolution across stroke phases is essential for clinical management.

Purpose:

  • To conduct a meta-analysis exploring the changes in apparent diffusion coefficient (ADC) during various stages of ischemic stroke.
  • To synthesize findings from existing literature to establish quantitative ADC values for hyper-acute, acute, sub-acute, and chronic stroke phases.

Summary:

  • A meta-analysis of 34 studies (20 English, 14 Chinese) revealed distinct pooled ADC values for different stroke stages.
  • Hyper-acute and acute stroke stages exhibited significantly lower ADC values (0.53 and 0.50 × 10(-3) s/mm, respectively) compared to penumbra and control groups.
  • ADC values demonstrated statistically significant differences across all stroke stages (hyper-acute, acute, sub-acute, chronic) when compared to control groups, with chronic stroke showing the highest ADC value (1.20 × 10(-3) s/mm).

Impact:

  • The findings suggest that ADC values can serve as a quantitative biomarker for assessing stroke severity and progression.
  • Quantitative ADC measurements can aid clinicians in guiding treatment strategies for ischemic stroke patients.
  • This meta-analysis provides a consolidated reference for ADC values in different stroke phases, supporting diagnostic accuracy and therapeutic planning.